Common Contracts
2 similar Shareholders' Loan Agreement contracts by Quintiles Transnational Corp
EX-10.03 4 g99270exv10w03.htm AMENDED AND RESTATED SHAREHOLDERS' LOAN AGREEMENT DATED 1-23-2006 CONTENTS CLAUSE PAGE 1A. AMENDMENT AND RESTATEMENT 2 THE SCHEDULE — INTERPRETATION 17 THIS AGREEMENT is made on 23 January 2006 Between:Shareholders' Loan Agreement • May 5th, 2020
Whereas: (A) Pursuant to the Shareholders’ Agreement dated 28 January 2005 and made between TLS and PharmaCo (Shareholders’ Agreement), (i) TLS and PharmaCo have jointly incorporated Holdco; and (ii) Holdco has incorporated a private limited company in Singapore known as Asia Pacific Pharmaceutical Investments Pte. Ltd. (Co. Reg. No. 200503853W) with its registered office at 150 Beach Road, #25-03/04 The Gateway West, Singapore 189720 (Newco1). (B) Pursuant to the Shareholders’ Loan Agreement dated 28 January 2005 and made between TLS, PharmaCo and Holdco (Shareholders’ Loan Agreement), TLS and PharmaCo have agreed to extend to Holdco on demand by Holdco, shareholders’ loans of up to US$150,000,000, comprising cash facilities of up to an aggregate principal amount not exceeding US$100,000,000, of which up to US$25,000,000 is to be granted by PharmaCo and up to US$75,000,000 is to be granted by TLS (subject to adjustments). Pursuant to a letter dated 28 December 2005 and made between TL
TLS BETA PTE. LTD. QUINTILES ASIA PACIFIC COMMERCIAL HOLDINGS, INC. PHARMACO INVESTMENTS LTD (formerly known as Transfarma Holdings Limited) ASIA PACIFIC PHARMACEUTICAL HOLDINGS PTE. LTD. AMENDED & RESTATED SHAREHOLDERS’ LOAN AGREEMENTShareholders' Loan Agreement • January 26th, 2006 • Quintiles Transnational Corp • Services-commercial physical & biological research
PharmaCo the amount of US$50,000,000 which is due and owing as a debt from Holdco to PharmaCo and treated as a loan from PharmaCo to Holdco under and subject to the terms of this Agreement (Newco2 Option Consideration Loan).
